(Q40918911)

24 September 2017

1 reference

title

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. (English)

1 reference

24 September 2017

Neu HC

1

1 reference

24 September 2017

Wilson AP

series ordinal

2

1 reference

24 September 2017

Grüneberg RN

series ordinal

3

1 reference

24 September 2017

publication date

1 April 1993

1 reference

24 September 2017

published in

Journal of Chemotherapy

1 reference

24 September 2017

volume

5

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

67-93

1 reference

Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

A method for assessing the quality of a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Effect of amoxycillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin and clavulanic acid in the treatment of urinary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Co-amoxiclav in recurrent acute otitis media: placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Experience with parenteral and sequential parenteral-oral amoxicillin/clavulanate (augmentin) in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Activities of amoxicillin and clavulanic acid combinations against urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Outpatient treatment of non-lactational breast abscesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Suspected postpartum endometritis: a controlled clinical trial of single-agent antibiotic therapy with Amox-CA (Augmentin) vs. ampicillin-metronidazole +/- aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Urinary tract infections with tissue penetration in children: cefotaxime compared with amoxycillin/clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Home treatment of febrile neutropenia: an empirical oral antibiotic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Effect of clavulanic acid and amoxycillin formulation against β-lactamase producing Gram-negative bacteria in urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Recurrent and penicillin V-resistant otitis media. A treatment study with amoxycillin/clavulanate and cefaclor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Effectiveness of intravenous Augmentin in the treatment of thalassaemic patients with Yersinia enterocolitica infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Clinical aspects of acute epiglottitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Effect of non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with "refractory" periodontal disease. (I). Clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Intravenous Augmentin in bacteraemia and severe invasive polymicrobial sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Further experience with augmentin in the treatment of skin infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Clinical efficacy of amoxycillin/clavulanate in laparoscopically confirmed salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Clinical experience with intravenous Augmentin in the treatment of paediatric infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Comparison of single-dose administration and three-day course of amoxicillin with those of clavulanic acid for treatment of uncomplicated urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin and clavulanic acid in the treatment of urinary tract infections in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin-clavulanic acid treatment of melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Tolerance of amoxicillin-clavulanic acid combination in the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxycillin, amoxycillin-clavulanic acid and metronidazole in the treatment of clue cell-positive discharge. A comparative clinical and laboratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Ambulatory treatment of suspected pelvic inflammatory disease with Augmentin, with or without doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

The crisis in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

Clinical Efficacy of Amoxycillin/Clavulanic Acid and Cefaclor in Acute Otitis Media

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1993.11739213

10.1080/1120009X.1993.11739213

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference